StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Benitec Biopharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Benitec Biopharma's operating income for the twelve months ending Jun 30, 2026 was -$51.19M. For fiscal 2026 it was -$51.19M. The highest annual figure on record is $2.58M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$51.19M–
FY2025Jun 30, 2025-$41.77M–
FY2024Jun 30, 2024-$22.49M–
FY2023Jun 30, 2023-$19.08M–
FY2022Jun 30, 2022-$17.85M–
FY2021Jun 30, 2021-$13.60M–
FY2020Jun 30, 2020-$8.28M-420.6%
FY2019Jun 30, 2019$2.58M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$14.43M–
Q3 FY2026CQ1 2026Mar 31, 2026-$13.58M–
Q2 FY2026CQ4 2025Dec 31, 2025-$13.38M–
Q1 FY2026CQ3 2025Sep 30, 2025-$9.80M–
Q4 FY2025CQ2 2025Jun 30, 2025-$9.83M–
Q3 FY2025CQ1 2025Mar 31, 2025-$15.34M–
Q2 FY2025CQ4 2024Dec 31, 2024-$10.81M–
Q1 FY2025CQ3 2024Sep 30, 2024-$5.79M–
Q4 FY2024CQ2 2024Jun 30, 2024-$5.55M–
Q3 FY2024CQ1 2024Mar 31, 2024-$4.14M–
Q2 FY2024CQ4 2023Dec 31, 2023-$6.93M–
Q1 FY2024CQ3 2023Sep 30, 2023-$5.87M–
Q4 FY2023CQ2 2023Jun 30, 2023-$4.55M–
Q3 FY2023CQ1 2023Mar 31, 2023-$4.34M–
Q2 FY2023CQ4 2022Dec 31, 2022-$5.61M–
Q1 FY2023CQ3 2022Sep 30, 2022-$4.58M–
Q4 FY2022CQ2 2022Jun 30, 2022-$4.74M–
Q3 FY2022CQ1 2022Mar 31, 2022-$3.46M–
Q2 FY2022CQ4 2021Dec 31, 2021-$4.84M–
Q1 FY2022CQ3 2021Sep 30, 2021-$4.82M–
Q4 FY2021CQ2 2021Jun 30, 2021-$3.86M–
Q3 FY2021CQ1 2021Mar 31, 2021-$3.79M–
Q2 FY2021CQ4 2020Dec 31, 2020-$3.26M–
Q1 FY2021CQ3 2020Sep 30, 2020-$2.69M–
Q4 FY2020CQ2 2020Jun 30, 2020-$2.89M–
Q3 FY2020CQ1 2020Mar 31, 2020-$2.11M–
Q2 FY2020CQ4 2019Dec 31, 2019-$2.11M–
Q1 FY2020CQ3 2019Sep 30, 2019-$1.17M–

More Benitec Biopharma figures

See a number that looks wrong?